BOCA RATON, Fla., Feb 18, 2010 (BUSINESS WIRE) -- --Company Generated Adjusted EBITDA of $5.4 Million for the Fourth Quarter, an Increase of approximately 180% y/y
--Adjusted EBITDA Margin increased 570 basis points y/y to 10.7%
--Fourth Quarter Net Income Grew to $2.6 Million or $0.09 Per Diluted Share
--Company Provides Full Year 2010 Revenues Guidance of $245-$255 Million
--Company Expects Full Year 2010 fully diluted EPS in the range of $0.56 - $0.63
Vitacost.com, Inc. /quotes/comstock/15*!vitc/quotes/nls/vitc (VITC 11.34, +0.44, +4.04%) , a leading online retailer and direct marketer of health and wellness products, today reported financial results for the fourth quarter and full year ended December 31, 2009.
Fourth Quarter of 2009 Operating Highlights Include:
-- Net Sales increased 32% y/y to $50.3 million, compared to $38.2 million for the fourth quarter of 2008.
-- Gross Profit Margin increased 450 basis points to 31.9% from the prior year period.
-- Sales and Marketing expenses as a percent of sales decreased 110 basis points year over year to 8.5% for the fourth quarter of 2009 compared to 9.6% in the comparable year period.
-- Adjusted EBITDA improved to $5.4 million, an increase of approximately 180% from the prior year period.
-- Adjusted EBITDA margin increased 570 basis points to 10.7% from the prior year period.
-- The Number of New Customers in the fourth quarter of 2009 increased 38% y/y to 184,293.
-- The Number of Orders in the fourth quarter of 2009 increased 26% y/y to 655,575.
Fourth Quarter 2009 Results
For the fourth quarter of 2009, net sales increased 32% to $50.3 million from net sales of $38.2 million for the fourth quarter of the prior year. Both of the Company's primary sales categories, propriety and third party products, contributed to this strong year-over-year increase by generating record fourth quarter results.
Gross profit for the fourth quarter of 2009 increased 53% to $16.0 million, compared to $10.5 million in the fourth quarter of the prior year. The Company's gross profit margin increased 450 basis points to 31.9% in the fourth quarter versus 27.4% in the fourth quarter of 2008. Overall, the gross profit margin improvement was primarily due to transitioning manufacturing of proprietary capsules and tablets from third-party manufacturers in-house, and increased purchasing power with third-party distributors and raw material suppliers due to higher sales volumes.
Operating income for the fourth quarter of 2009 was $3.7 million compared to $0.5 million in the same period a year ago. The Company's operating margin expanded to 7.3% from 1.4% for the same period last year. This improvement was due to strong net sales growth, leverage of sales and marketing expense, and the strength of the Company's proven business model.
Adjusted EBITDA (earnings before interest, taxes, depreciation, amortization and related non-cash compensation expense) for the fourth quarter of 2009 increased approximately 180% y/y to $5.4 million, compared to $1.9 million in the previous year. The Company's EBITDA margin increased 570 basis points to 10.7% in the fourth quarter versus 5.0% in the fourth quarter of 2008.
Net income for the fourth quarter of 2009 was $2.6 million, or $0.09 per diluted share calculated on a weighted average fully diluted share count of 28.5 million shares, versus a net loss of $0.6 million or ($0.02) per share for the comparable period last year. The Company had approximately 22.8 million shares outstanding pre IPO and issued approximately 4.4 million new shares for the IPO during the last week of September.
"We achieved record sales for the fourth quarter and full year of 2009 and are on track to deliver strong results in 2010. Fourth quarter net sales increased in our two primary net sales sources -- third party products and propriety products -- underscoring our expanding product offering as well as customer growth," said Ira Kerker, Vitacost's Chief Executive Officer. "The improved gross and operating margins during 2009 illustrate the leverage in our business model and with the planned expansion of our distribution and manufacturing facilities in 2010; we believe we are well positioned for increased sales, margin improvement and earnings growth for many years to come."
Full Year 2009 Results
For the full year of 2009, net sales increased 33.6% to $191.8 million compared to $143.6 million in the same period last year.
The Company's operating cash flow was $14.9 million for the full year of 2009 compared to a use of $0.6 million in 2008. Adjusted EBITDA was $24.4 million for the full year of 2009 compared to $5.3 million for the previous year.
Excluding the $10.9 million of one-time, non-cash stock option expense recorded in the third quarter, full year 2009 net income was $12.9 million, or $0.52 per diluted share, calculated on 24.7 million shares outstanding compared to breakeven net income or $0.00 per diluted share, for full year 2008. The Company's GAAP net income, which includes the $10.9 million of one-time, non-cash stock-based compensation expense in connection with the recent initial public offering, was $5.9 million or $0.24 per fully diluted share for the full year of 2009 compared with breakeven net income $0.00 per fully diluted share for the full year of 2008.
The Company ended the fourth quarter of 2009 with cash, cash equivalents, and short-term investments, of $44.4 million as of December 31, 2009.
Richard Smith, Chief Financial Officer, commented, "Our strong operating cash flow of $14.9 million for the full year of 2009 combined with our recent initial public offering has us well positioned to complete our distribution and manufacturing facility expansion as well as sufficient capital to increase our competitive advantage. For instance, we have utilized our infrastructure to increase the number of SKU's that we offer our customers to over 30,000 from 23,000 we had previously reported and we plan to end 2010 with approximately 60,000 SKU's."
For the first quarter of 2010, the Company expects revenue to be in the range of $58 to $60 million. Earnings per diluted share for the first quarter are expected to be in the range of $0.14 to $0.15 per diluted share calculated with fully diluted shares outstanding of 28.9 million.
For the full year ending December 31, 2010 the Company expects revenue to be in the range of $245 to $255 million. The Company expects its net income to be in the range of $16.5 to $18.5 million which equates to an increase of 28% - 43% y/y, compared to the full year 2009 net income of $12.9M which excludes the one-time, non-cash stock compensation expense. The Company expects earnings per diluted share to be in the range of $0.56 to $0.63 calculated with fully diluted shares outstanding of 29.5 million.
The Company expects its EBITDA for the full year of 2010 to be in the range of $32.5 to $34 million with approximately $4.0 million of depreciation and amortization for the full year.
A copy of historical e-commerce metrics is available on the Company's website at www.vitacost.com/earnings.
About Vitacost.com, Inc.
Vitacost.com, Inc. (Symbol: VITC) is a leading online retailer and direct marketer of health and wellness products, including dietary supplements such as vitamins, minerals, herbs or other botanicals, amino acids and metabolites, as well as cosmetics, organic body and personal care products, sports nutrition and health foods. Vitacost.com, Inc. sells these products directly to consumers through its website, www.vitacost.com, as well as through its catalogs. Vitacost.com, Inc. strives to offer its customers the broadest product selection supported by current scientific and medical research at the best value, while providing superior customer service and timely and accurate delivery.
Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements made herein, which include management's expected results of operations for the first quarter of 2010, and the full year of 2010, involve known and unknown risks and uncertainties, which may cause Vitacost's actual results in current or future periods to differ materially from forecasted results. Those risks and uncertainties include, among other things, the current global economic downturn or recession; difficulty expanding its manufacturing and distribution facilities; significant competition in its industry; unfavorable publicity or consumer perception of its products on the Internet; the incurrence of material product liability and product recall costs; Inability to defend intellectual property claims; costs of compliance and its failure to comply with government regulations; its failure to keep pace with the demands of our customers for new products; disruptions in its manufacturing system, including information technology systems, or losses of manufacturing certifications; and the lack of long-term experience with human consumption of some of its products with innovative ingredients. Those and other risks are more fully described in Vitacost's filings with the Securities and Exchange Commission, including the Registration Statement on Form S-1, as amended, filed in connection with the Company's initial public offering as well as the Company's form 10-Q filed for the third quarter of 2009.